PMD Forensic Analyst with Investment Insights

I am a retired P.M.D. Forensic Analyst with Investment Insights in economics who created theorems being bantered about for the Austerity v. Coase Oppression Investing Demographic Winter.  I write frequently to those trying to "Get it ... more

ALL CONTRIBUTIONS

E The Dream Team Disruptors - Einstein's In Biopharma 2020-2021
The trends in the final months of 2020 and moving into 2021 have assembled "The Dream-Team" in saving many lives and the losses in functionalities in those infected with COVID-19 World-Wide Pandemic.
Read
E Doubling Down On China's COVID-19 Bio-Tech Disrupters
Looking for Alpha Undervalued Bio-Tech COVID-19 Disrupters.
Read
E Blockbuster SAR-CoV2 Disrupters Pre-ICU / Admitted ICU Patient Treatments & COVID-19 T-Cell Vaccine Horizon
In recent months, there has been a flurry of activity within the clinical trial sector. When all trial types are considered, there are over 400 studies exploring approaches to diagnosing, treating, or preventing COVID-19.
Read
E Staying Long Against High-Frequency Traders
Time to send the message for the Institutional Investors to run back into ownership--long positions, and bring the bullish goring of the short-selling bears on $INO to break their trading funds within their banks.
Read
E The Greatest Show On Earth - Not Really - It's Getting Ugly Dangerous
Optimism in the market can drive prices to lofty levels that are unsustainable and that don’t reflect the actual value of a company. The presence of short sellers in the marketplace can help to re-balance stock prices.
Read
E It's Time To Pull The Plug On The Shorter's Or Raging Bearish Market-Maker(s)
The market safety breaker or current circuits can't stop the algorithm short-trading of an eventual bearish market crashing by the very real forces being played out.
Read

Comments

Latest Comments
The Dream Team Disruptors - Einstein's In Biopharma 2020-2021
6 days ago

Thank you William for the kind thoughts.

In this article: AZN, JNJ, PFE, CYDY, ABIO, REGN, SPPI, MRNA, AXDX, CAPR, MESO, NVS
Blockbuster SAR-CoV2 Disrupters Pre-ICU / Admitted ICU Patient Treatments & COVID-19 T-Cell Vaccine Horizon
3 months ago

What will bring all back to work! Joe Biden is clueless... Keeping the eyes on the prize! POTUS Capricor, CAPR yesterday, beat on all numbers and has brought a VLP Vaccine into the long-term solutions FDA TRIALS CAP-1002. talkmarkets.com/.../blockbuster-sar-cov2-disrupters-pre-icu--admitted-icu-patient-treatments--covid-19-t-cell-vaccine-horizon PT $14 - $24 3-12 month outlook.

In this article: CAPR, ATHX
Staying Long Against High-Frequency Traders
3 months ago

What will bring all back to work! Joe Biden is clueless... Keeping the eyes on the prize! POTUS Capricor, CAPR yesterday, beat on all numbers and has brought a VLP Vaccine into the long-term solutions FDA TRIALS CAP-1002. talkmarkets.com/.../blockbuster-sar-cov2-disrupters-pre-icu--admitted-icu-patient-treatments--covid-19-t-cell-vaccine-horizon PT $14 - $24 3-12 month outlook.

In this article: GSK, SNY, INO
Staying Long Against High-Frequency Traders
4 months ago

Keeping the eyes on the prize:

Good connecting article for why the PT had hit the 52 weeks high $12.32 and maybe the reason for the August 6th or 8th earnings report in jacking the share price towards becoming a true M&A candidate or given the blessings of the FDA's approval for CAP-1002 BLA filing for uses.

READ:

talkmarkets.com/.../blockbuster-sar-cov2-disrupters-pre-icu--admitted-icu-patient-treatments--covid-19-t-cell-vaccine-horizon

READ:

endpts.com/microcap-capricor-soars-on-interim-phii-dmd-data-showing-functional-benefit-for-older-patients/

In this article: GSK, SNY, INO
Blockbuster SAR-CoV2 Disrupters Pre-ICU / Admitted ICU Patient Treatments & COVID-19 T-Cell Vaccine Horizon
4 months ago

Good connecting article for why the PT had hit the 52 weeks high $12.32 and maybe the reason for the August 6th or 8th earnings report in jacking the share price towards becoming a true M&A candidate or given the blessings of the FDA's approval for CAP-1002 BLA filing for uses.

READ:

endpts.com/microcap-capricor-soars-on-interim-phii-dmd-data-showing-functional-benefit-for-older-patients/

In this article: CAPR, ATHX
Blockbuster SAR-CoV2 Disrupters Pre-ICU / Admitted ICU Patient Treatments & COVID-19 T-Cell Vaccine Horizon
4 months ago

Very Important *****FYI for those seeking the best and earliest buy for both MESO with their BLA pending FDA approval on Remestence-L and CAPR CAP-1002 are just a few we are closely watching.

READ:

bioinformant.com/capricor-developing-treatment-dmd/ Inivio INO just got their BLA approval for their HPV suite of critical advancements in helping those stricken with Throat complications of HPV and that in critically advancing their VGX-3100 towards getting FDA final approvals.

Capricor CAPR has a few irons in the fire coming up when they present their upcoming second-quarter earnings and corporation pipeline status.

READ:

talkmarkets.com/.../blockbuster-sar-cov2-disrupters-pre-icu--admitted-icu-patient-treatments--covid-19-t-cell-vaccine-horizon

The first big iron for CAPR comes with a pending BLA for getting or meeting Orphan Drug Approval Status for their CAP-1002 for male boys and younger adult males with Duchenne muscular dystrophy (DMD) in 7 Major Markets.

This Iron is also quite remarkable with the incredible successes from the uses of MSCs and Exosome biotechnology advancements and the repurposing of their most current pipeline candidates awaiting approvals from the FDA for the accepted treatment protocols COVID-19 SARSCoV2; the eventual Orphan Drug Status for both Capricor CAPR CAP-1002 and Mesoblast LTD MESO for their Remestence-L.

Again, both MESO and CAPR for battling and achieving a true Disrupter Status in this war against China's born novel Coronavirus affecting our entire plant, since possibly October of 2019, when China kept this secret biological weapon hidden from the rest of the entire living masses around our world economies.

Keep up with the currently approved study for CAPR below as a link is provided. ClinicalTrials.gov identifier (NCT number): NCT04338347

READ:

https://clinicaltrials.gov/ct2w/NCT04338347

In this article: CAPR, ATHX
Staying Long Against High-Frequency Traders
4 months ago

Very Important *****FYI for those seeking the best and earliest buy for both MESO with their BLA pending FDA approval on Remestence-L and CAPR CAP-1002 are just a few we are closely watching. READ: bioinformant.com/capricor-developing-treatment-dmd/ Inivio INO just got their BLA approval for their HPV suite of critical advancements in helping those stricken with Throat complications of HPV and that in critically advancing their VGX-3100 towards getting FDA final approvals. Capricor CAPR has a few irons in the fire coming up when they present their upcoming second-quarter earnings and corporation pipeline status. READ: talkmarkets.com/.../blockbuster-sar-cov2-disrupters-pre-icu--admitted-icu-patient-treatments--covid-19-t-cell-vaccine-horizon The first big iron for CAPR comes with a pending BLA for getting or meeting Orphan Drug Approval Status for their CAP-1002 for male boys and younger adult males with Duchenne muscular dystrophy (DMD) in 7 Major Markets. This Iron is also quite remarkable with the incredible successes from the uses of MSCs and Exosome biotechnology advancements and the repurposing of their most current pipeline candidates awaiting approvals from the FDA for the accepted treatment protocols COVID-19 SARSCoV2; the eventual Orphan Drug Status for both Capricor CAPR CAP-1002 and Mesoblast LTD MESO for their Remestence-L. Again, both MESO and CAPR for battling and achieving a true Disrupter Status in this war against China's born novel Coronavirus affecting our entire plant, since possibly October of 2019, when China kept this secret biological weapon hidden from the rest of the entire living masses around our world economies. Keep up with the currently approved study for CAPR below as a link is provided. ClinicalTrials.gov identifier (NCT number): NCT04338347 READ: https://clinicaltrials.gov/ct2/shoVery Important *****FYI for those seeking the best and earliest buy for both MESO with their BLA pending FDA approval on Remestence-L and CAPR CAP-1002 are just a few we are closely watching. READ: bioinformant.com/capricor-developing-treatment-dmd/ Inivio INO just got their BLA approval for their HPV suite of critical advancements in helping those stricken with Throat complications of HPV and that in critically advancing their VGX-3100 towards getting FDA final approvals. Capricor CAPR has a few irons in the fire coming up when they present their upcoming second-quarter earnings and corporation pipeline status. READ: talkmarkets.com/.../blockbuster-sar-cov2-disrupters-pre-icu--admitted-icu-patient-treatments--covid-19-t-cell-vaccine-horizon The first big iron for CAPR comes with a pending BLA for getting or meeting Orphan Drug Approval Status for their CAP-1002 for male boys and younger adult males with Duchenne muscular dystrophy (DMD) in 7 Major Markets. This Iron is also quite remarkable with the incredible successes from the uses of MSCs and Exosome biotechnology advancements and the repurposing of their most current pipeline candidates awaiting approvals from the FDA for the accepted treatment protocols COVID-19 SARSCoV2; the eventual Orphan Drug Status for both Capricor CAPR CAP-1002 and Mesoblast LTD MESO for their Remestence-L. Again, both MESO and CAPR for battling and achieving a true Disrupter Status in this war against China's born novel Coronavirus affecting our entire plant, since possibly October of 2019, when China kept this secret biological weapon hidden from the rest of the entire living masses around our world economies. Keep up with the currently approved study for CAPR below as a link is provided. ClinicalTrials.gov identifier (NCT number): NCT04338347 READ: https://clinicaltrials.gov/ct2w/NCT04338347

In this article: GSK, SNY, INO
Blockbuster SAR-CoV2 Disrupters Pre-ICU / Admitted ICU Patient Treatments & COVID-19 T-Cell Vaccine Horizon
4 months ago

Very Important *****FYI for those seeking the best and earliest buy for both MESO with their BLA pending FDA approval on Remestence-L and CAPR CAP-1002 are just a few we are closely watching. READ: bioinformant.com/capricor-developing-treatment-dmd/ Inivio INO just got their BLA approval for their HPV suite of critical advancements in helping those stricken with Throat complications of HPV and that in critically advancing their VGX-3100 towards getting FDA final approvals. Capricor CAPR has a few irons in the fire coming up when they present their upcoming second-quarter earnings and corporation pipeline status. READ: talkmarkets.com/.../blockbuster-sar-cov2-disrupters-pre-icu--admitted-icu-patient-treatments--covid-19-t-cell-vaccine-horizon The first big iron for CAPR comes with a pending BLA for getting or meeting Orphan Drug Approval Status for their CAP-1002 for male boys and younger adult males with Duchenne muscular dystrophy (DMD) in 7 Major Markets. This Iron is also quite remarkable with the incredible successes from the uses of MSCs and Exosome biotechnology advancements and the repurposing of their most current pipeline candidates awaiting approvals from the FDA for the accepted treatment protocols COVID-19 SARSCoV2; the eventual Orphan Drug Status for both Capricor CAPR CAP-1002 and Mesoblast LTD MESO for their Remestence-L. Again, both MESO and CAPR for battling and achieving a true Disrupter Status in this war against China's born novel Coronavirus affecting our entire plant, since possibly October of 2019, when China kept this secret biological weapon hidden from the rest of the entire living masses around our world economies. Keep up with the currently approved study for CAPR below as a link is provided. ClinicalTrials.gov identifier (NCT number): NCT04338347 READ: https://clinicaltrials.gov/ct2/show/NCT04338347

In this article: CAPR, ATHX
Blockbuster SAR-CoV2 Disrupters Pre-ICU / Admitted ICU Patient Treatments & COVID-19 T-Cell Vaccine Horizon
4 months ago

I agree, the title of the article was a mouthful! I had a hard time shorting it, mostly due to the sure nature of covering a myriad of treatments and vaccines for ongoing war.

I will use my reply this morning, in taking efforts on getting out my frustrations for a NOVEL CORONAVIRUS that has killed hundreds of thousands, and yet has not met it's match to date.

Yes, I said WAR--being waged upon China's Deadly Gift--sent around the world with a Kiss...

China's well documented "Evil Intents" by the very nature of evil, as driven China determination in becoming the one and only superpower over our free democracies we all seemingly hold so dear.

I say this, because, it seems our LEFT-WING MEDIA and the Tech-Valley of Google's, Amazon's, Apple's, Twitter's, and a host of Democratic DNC elected Governor's, Mayor's, and elected officials throughout the many states and cities; seeing out and out rioting, causing untold damages throughout our United States.

Just getting out my frustrations this morning. I just can't believe the lengths the LEFT-WING Media has taken in trying to effect a presidential election in 2020.

We can all agree, when one can stand behind the cause of when an African American, who had been suffocated with a lethally used choke hold--as the one loan officer wouldn't release pressure--as many were yelling at the other two law enforcement officers to stop George's death as he was killed in Minneapolis, Minnesota, George Floyd's death, at the hands then, three identified law enforcement officers, with one actually being the stone blooded killer.

NO ONE can disagree with the outrage in the senseless killing of George Floyd, in wear legal protest is quite a correct response.

We in NO WAY or in ANY SHAPE, CONDONE what has gone on behind those that lead BLM condoning the extremes of lawlessness, an increase in civilian death's along with those wearing the BLUE as the violence seen over these past several months And within their past history's.

NO ONE should stand-by and allow lawlessness and outright Anarchies, as being played out in Portland, Seattle, Chicago, and other televised news coming out from a trusted NEWS SOURCE of FOX News; as I recommend many to turn towards, if they want the truth and not the FAKE NEWS Agendas.

Yes, FAKE NEWS AGENDAS being waged against our own 1st amendment rights, and though, I do find some other news outlets not afraid in getting out the truth behind all these very Evil and Diabolical efforts being played out right before all of our very eyes.

In this article: CAPR, ATHX
1 to 10 of 29 comments
1 2 3

STOCKS I FOLLOW

AAPL Apple Inc.
ALXN Alexion Pharmaceuticals, Inc.
AMT American Tower Corporation
AMZN Amazon.com Inc.
ATHX Athersys Inc.
ATVI Activision Blizzard Inc
ATW Atwood Oceanics Inc.
AZN AstraZeneca Group plc
BA The Boeing Company
BNTX BioNTech SE
BRK-B BERKSHIRE HATHAWAY CLASS B
CAPR Capricor Therapeutics, Inc.
CSCO Cisco Systems Inc.
DIA SPDR Dow Jones Industrial Average
DIS The Walt Disney Company
DVAX Dynavax Technologies Corporation
F Ford Motor Company
FB Facebook Inc
GE General Electric Company
GGN The Gabelli Global Gold, Natural Resources & Income Trust
GILD Gilead Sciences Inc.
GM General Motors Company
GOOG Alphabet Inc. (Google)
GS Goldman Sachs Group Inc.
GSK GlaxoSmithKline
HEI HEICO Corporation
INO Inovio Pharmaceuticals, Inc.
INTC Intel Corporation
JBLU JetBlue Airways Corporation
KMI Kinder Morgan Inc.
LMT Lockheed Martin
MESO Mesoblast Inc.
MKL Markel Corporation
MRNA Moderna, Inc.
MSFT Microsoft Corporation
MTCH Match Group, Incorporated
NVAX Novavax Inc.
NVDA Nvidia Corporation
PFE Pfizer Inc.
PSEC Prospect Capital Corporation
REGN Regeneron Pharmaceuticals, Inc.
SNY Sanofi
T AT&T Inc.
TDG Transdigm Group Incorporated
TSLA Tesla Motors Inc.
UA Under Armour Class C
WYNN Wynn Resorts Limited
XBI SPDR S&P Biotech ETF
XOM Exxon Mobil Corporation
Load More

TWEETS

PERSONAL BLOG

Latest Posts
Moving Stage Right — Forensics Exposes The Election Truths In 2020
Finding all the smoking guns who have tried to stay hidden in this 2020 Presidential Election. Forensics, as I am, a retired expert in bringing the hidden to be found and exposed. AI developers use Patterns and Anomalies programmed image analysis.
What's In An FDA Fast-Track Stock Issues Like (DERM) Or (INO) You Need To Know About Too Invest?
The question, "Orphan Drug Act of 1983 Approval", whether from the FDA, or even more impressive, the World Orphan Drug Congress, together with over 50 countries, in the advancement of Clinic Development for acute and also rare medical conditions.

Work Experience

CIO
US Silent Partner, Inc.
June 1991 - August 2005 (14 years 5 months)

Software Developer and Analytical Crystal Report Developer with Project Management Director Over Advocate Connections Development.

COO
South Florida Diagnostics
October 1987 - May 1994 (6 years 9 months)

Managed all of the daily operations and financial operations of the corporation.

Education

Palm Beach State College
Bachelor
2009 / 2018
Business Administration (B.B.A.), Business Administration and Management, General, 4.0
College of DuPage
2008 / 2010
Associate of Science (A.S.), EMS Management

Publications